Oclassen Pharmaceuticals was a privately held pharmaceutical company founded in 1985 until acquired by Watson Pharmaceuticals, Inc., in 1997. Watson Pharmaceuticals, Inc., (also incorporated in 1985), having acquired Oclassen Pharmaceuticals (Oclassen Dermatologics) also acquired the marketing rights contained within the agreement with Eli Lilly to market Cinobac.
Oclassen Pharmaceuticals, a privately held pharmaceutical company founded in 1985, was acquired by Watson Pharmaceuticals, Inc., in 1997.  Watson Pharmaceuticals, Inc., which was also established in 1985, obtained the marketing rights to Cinobac from Eli Lilly after acquiring Oclassen Pharmaceuticals (specifically its dermatology division).